Autopsy report · NCT05084456

Oral Docetaxel in Patients With Normal or Impaired Liver Function

“Pending further development”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Modra Pharmaceuticals

Sponsor type

Industry

Conditions

Solid Tumor, Adult; Impaired Liver Function

Interventions

ModraDoc006/r

Participants

0

Sites

1

Countries

Netherlands

Trials that died the same way

• Fecal Microbiota Transplantation for Patients With Chronic Widespread Pain
  “Pending for funding” (66% match in meaning)
• Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
  “Pending additional funding.” (64% match in meaning)
• Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML
  “Development discontinued” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.